Earnings History Data for Lucid Diagnostics Inc. (LUCD) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Lucid Diagnostics Inc.
Lucid Diagnostics Inc. is a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. Lucid Diagnostics Inc. is based in NEW YORK.
Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
13-11-2024 | PM | LUCD | Lucid Diagnostics Inc. | 56.69 | -0.22 | -0.18 | -0.27 | Lucid Diagnostics reports Q3 results [11/13/2024 10:59 AM] |
1.04 | 0.04 (4.00%) |
1.11 | 0.11 (11.00%) |
0.63 - 1.58 | 1,441,146 | 390,000 | 72,987 | ||
12-08-2024 | PM | LUCD | Lucid Diagnostics Inc. | 40.74 | -0.23 | 0.00 | -0.26 | Lucid Diagnostics Non-GAAP EPS of -$0.20 misses by $0.02, revenue of $0.98M misses by $0.24M [8/12/2024 8:09 AM] |
0.8350 | 0.04 (5.70%) |
0.85 | 0.06 (7.59%) |
0.63 - 1.72 | 138,789 | 130,000 | 3,059 | ||
13-05-2024 | PM | LUCD | Lucid Diagnostics Inc. | 44.85 | -0.23 | 0.00 | -0.32 | Lucid Diagnostics Non-GAAP EPS of -$0.21 beats by $0.01, revenue of $1M misses by $0.05M [5/13/2024 8:10 AM] |
0.9481 | 0.0 (0.39%) |
1.01 | 0.07 (6.95%) |
0.63 - 1.85 | 116,515 | 370,000 | 5,626 | ||
|
||||||||||||||||||
25-03-2024 | AH | LUCD | Lucid Diagnostics Inc. | 49.58 | -0.26 | 0.00 | -0.29 | Lucid Diagnostics reports preliminary Q4 results [3/25/2024 5:55 PM] |
0.9904 | -0.07 (-6.57%) |
1.06 | 0.0 (0.00%) |
0.97 - 1.85 | 407,060 | 220,000 | 457 | ||
13-11-2023 | PM | LUCD | Lucid Diagnostics Inc. | 50.72 | -0.27 | 0.00 | -0.39 | Lucid Diagnostics Non-GAAP EPS of -$0.22 in-line, revenue of $0.8M beats by $0.01M [11/14/2023 1:06 AM] |
1.27 | 0.11 (9.48%) |
0.0 | 0.0 (0.00%) |
1.04 - 2.36 | 50,616 | 40,000 | 0 | ||
15-05-2023 | PM | 4:40 PM ET (May 15) |
LUCD | Lucid Diagnostics Inc. | 66.39 | -0.32 | 0.00 | -0.35 | Lucid Diagnostics Non-GAAP EPS of -$0.24 beats by $0.06, revenue of $0.4M beats by $0.17M [5/16/2023 2:41 AM] |
1.50 | 0.01 (0.67%) |
1.48 | -0.01 (-0.67%) |
1.11 - 3.64 | 26,204 | 40,000 | 3,349 | |
14-03-2023 | PM | LUCD | Lucid Diagnostics Inc. | 50.45 | -0.29 | 0.00 | -0.32 | Lucid Diagnostics Non-GAAP EPS of -$0.15 beats by $0.17, revenue of $0.11M misses by $0.27M [3/14/2023 2:15 AM] |
1.73 | 0.12 (7.45%) |
0.0 | 0.0 (0.00%) |
1.11 - 3.64 | 160,561 | 130,000 | 0 | ||
14-11-2022 | PM | 4:25 PM ET (Nov 14) |
LUCD | Lucid Diagnostics Inc. | 81.77 | -0.39 | 0.00 | -0.49 | Lucid Diagnostics Non-GAAP EPS of -$0.28 in-line, revenue of $0.08M misses by $1.67M [11/15/2022 7:25 AM] |
1.99 | -0.28 (-12.38%) |
2.12 | -0.15 (-6.61%) |
1.51 - 10.90 | 160,369 | 50,000 | 4,238 | |
11-05-2022 | AH | After the close (May 11) |
LUCD | Lucid Diagnostics Inc. | 73.97 | -0.35 | 0.00 | 0.00 | Lucid Diagnostics Non-GAAP EPS of -$0.23 beats by $0.01, revenue of $0.2M misses by $0.25M [5/11/2022 4:04 PM] |
1.98 | 0.12 (6.45%) |
1.91 | 0.05 (2.69%) |
1.79 - 13.52 | 125,409 | 160,000 | 668 | |
|